Details for 2017814228
Up to date per 05.04.2026
Actions
Details for 2017814228
Granted/Registered
European Patent
24.04.2019 A
16.03.2022 B1
16.06.2016
US
201662351231 P
C12N 15/09 20060101AFI20200117BHEP
Owner
Adverum Biotechnologies, Inc.800 Saginaw Drive Redwood City, CA 94063US
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
BLUMENKRANZ, Mark1035 O'Brien Drive Suite A Menlo Park, CA 94025US
GASMI, Mehdi1035 O'Brien Drive Suite A Menlo Park, CA 94025US
Information about Fees